These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12430178)

  • 1. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.
    Hyder SM; Stancel GM
    Cancer Lett; 2002 Jul; 181(1):47-53. PubMed ID: 12430178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
    Wu J; Liang Y; Nawaz Z; Hyder SM
    Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
    Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
    Hyder SM; Chiappetta C; Stancel GM
    Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
    Rosenberg Zand RS; Grass L; Magklara A; Jenkins DJ; Diamandis EP
    Breast Cancer Res Treat; 2000 Mar; 60(1):1-8. PubMed ID: 10845803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
    Hyder SM; Chiappetta C; Stancel GM
    Cancer Lett; 2000 Aug; 156(1):101-7. PubMed ID: 10840165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyr61 promotes breast tumorigenesis and cancer progression.
    Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
    Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).
    McClelland RA; Barrow D; Madden TA; Dutkowski CM; Pamment J; Knowlden JM; Gee JM; Nicholson RI
    Endocrinology; 2001 Jul; 142(7):2776-88. PubMed ID: 11415996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.
    Greb RR; Heikinheimo O; Williams RF; Hodgen GD; Goodman AL
    Hum Reprod; 1997 Jun; 12(6):1280-92. PubMed ID: 9222018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription.
    Nawaz Z; Stancel GM; Hyder SM
    Cancer Res; 1999 Jan; 59(2):372-6. PubMed ID: 9927049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.